Neuropeptides are involved in many biological processes, including reward mechanisms and memory. Several peptides are thought to contribute to the physiological response to some drugs of abuse, and it is likely that additional peptides are involved. The overall focus of this grant application is to study neuropeptides and the processing enzymes that produce the neuropeptides, with an emphasis on the effects of drugs of abuse on peptide levels and processing. Peptide levels are typically measured by radioimmuno or radioreceptor assays. While sensitive, these techniques have several restrictions;the most serious is that they are limited to known peptides and a specific question. Recent developments in mass spectrometry and isotopic labeling have led to a fundamental change in the ways that peptides can be measured. Now, it is possible to know the precise molecular form of the peptide being measured. Furthermore/the approach can detect a wide range of peptides, including novel ones. Using a quantitative mass spectrometry-based peptidomics technique, over 100 peptides can be detected in a single experiment. This technique will be used in Aim 1 to evaluate the physiological role of various peptide processing enzymes by examining relative levels of peptides in mutant or 'knock-out'mice that lack carboxypeptidase E or prohormone convertase activity. The peptidomics technique will be used in Aim 2 to determine which peptides are up- or down-regulated by chronic and acute treatment of wild type mice with cocaine, morphine, or methamphetamine.
Aim 3 will investigate the physiological role of peptides found in Aims 1 and 2, with a focus on paradigms related to drug abuse. Collectively, these studies will greatly expand our knowledge about neuropeptides and neuropeptide processing enzymes in general, and will identify targets for many further studies on the role of particular peptides in the short- and long-term adaptations to drugs of abuse.
|Fricker, Lloyd D; Devi, Lakshmi A (2018) Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacol Ther 185:26-33|
|Berezniuk, Iryna; Rodriguiz, Ramona M; Zee, Michael L et al. (2017) ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine. J Neurochem 143:268-281|
|Gomes, Ivone; Bobeck, Erin N; Margolis, Elyssa B et al. (2016) Identification of GPR83 as the receptor for the neuroendocrine peptide PEN. Sci Signal 9:ra43|
|Dasgupta, Sayani; Yang, Ciyu; Castro, Leandro M et al. (2016) Analysis of the Yeast Peptidome and Comparison with the Human Peptidome. PLoS One 11:e0163312|
|Lopes, Mark William; Sapio, Matthew R; Leal, Rodrigo B et al. (2016) Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules. PLoS One 11:e0152905|
|Fricker, Lloyd D (2015) Limitations of Mass Spectrometry-Based Peptidomic Approaches. J Am Soc Mass Spectrom 26:1981-91|
|Sapio, Matthew R; Vessaz, Monique; Thomas, Pierre et al. (2015) Novel carboxypeptidase A6 (CPA6) mutations identified in patients with juvenile myoclonic and generalized epilepsy. PLoS One 10:e0123180|
|Dasgupta, Sayani; Fishman, Michael A; Mahallati, Hana et al. (2015) Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington's Disease. PLoS One 10:e0145333|
|Sapio, Matthew R; Fricker, Lloyd D (2014) Carboxypeptidases in disease: insights from peptidomic studies. Proteomics Clin Appl 8:327-37|
|Wardman, Jonathan H; Fricker, Lloyd D (2014) ProSAAS-derived peptides are differentially processed and sorted in mouse brain and AtT-20 cells. PLoS One 9:e104232|
Showing the most recent 10 out of 125 publications